Isomorphic Labs announces Series B investment round
Our Team Our Tech Partnerships
Life at IsoWork with UsJob Openings
Announcement
Isomorphic Labs announces Series B investment round
May 12, 2026
min Read
min Read
min Read
min Read
min listen
min watch
[](https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round#)
Table of Contents
Listen:
Isomorphic Labs announces it has raised $2.1 Billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs’ global capital base.
Isomorphic Labs was founded with the ambition to leverage the power of AI to reimagine and accelerate drug discovery to bring much-needed treatments to millions of patients globally. The company aims to apply its pioneering AI drug design engine (IsoDDE) to deliver biomedical breakthroughs and is advancing drug design programs across multiple therapeutic areas and drug modalities.
Read more in the news release below.
Isomorphic Labs announces
$2.1 Billion funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.
Follow us
Related